Effect of rituximab on the incidence of GVHD in lymphoma patients who received the BEAM-conditioning and an allogeneic stem cell transplantation.

被引:0
|
作者
Khouri, IF [1 ]
Saliba, RM [1 ]
Couriel, DR [1 ]
Okoroji, GJ [1 ]
Acholonu, S [1 ]
Maadani, F [1 ]
Champlin, RE [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4980
引用
收藏
页码:326B / 326B
页数:1
相关论文
共 50 条
  • [31] Allogeneic hemopoietic stem cell transplantation for patients with lymphoma
    Raiola, AM
    Lamparelli, T
    di Grazia, C
    Oneto, R
    Bruno, B
    Gualandi, F
    Bregante, S
    Dominietto, A
    Galbusera, V
    Tedone, E
    Frassoni, F
    van Lint, MT
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S6 - S7
  • [32] Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis
    Salhotra, Amandeep
    Mei, Matthew
    Stiller, Tracey
    Mokhtari, Sally
    Herrera, Alex F.
    Chen, Robert
    Popplewell, Leslie
    Zain, Jasmine
    Ali, Haris
    Sandhu, Karamjeet
    Budde, Elizabeth
    Nademanee, Auayporn
    Forman, Stephen J.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (02) : 287 - 292
  • [33] Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation
    Na, K-S
    Yoo, Y-S
    Mok, J. W.
    Lee, J. W.
    Joo, C-K
    BONE MARROW TRANSPLANTATION, 2015, 50 (11) : 1459 - 1464
  • [34] Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation
    K-S Na
    Y-S Yoo
    J W Mok
    J W Lee
    C-K Joo
    Bone Marrow Transplantation, 2015, 50 : 1459 - 1464
  • [35] Incidence and risk factors for developing limbic encephalitis in allogeneic stem cell transplantation.
    Braden, Christopher D.
    Alore, Patrick L.
    Stiff, Patrick J.
    Rodriguez, Tulio E.
    Parthasarathy, Mala
    Toor, Amir A.
    Macken, Micheal P.
    BLOOD, 2006, 108 (11) : 826A - 826A
  • [36] Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.
    Potter, MN
    Grace, SC
    Teehan, C
    Ethell, M
    Theocharous, P
    Claudé, R
    Hale, G
    Waldmann, H
    Prentice, HG
    BLOOD, 2000, 96 (11) : 476A - 476A
  • [37] Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
    Ratanatharathorn, Voravit
    Logan, Brent
    Wang, Dan
    Horowitz, Mary
    Uberti, Joseph P.
    Ringden, Olle
    Gale, Robert Peter
    Khoury, Hanna
    Arora, Mukta
    Spellman, Stephen
    Cutler, Corey
    Antin, Joseph
    Bornhaeuser, Martin
    Hale, Gregory
    Verdonck, Leo
    Cairo, Mitchell
    Gupta, Vikas
    Pavletic, Steven
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) : 816 - 824
  • [38] Pulmonary involvement in chronic GVHD occurring after allogeneic peripheral blood stem cell transplantation.
    Hertenstein, B
    Gabrysiak, T
    Eder, M
    Dietrich, H
    Novotny, J
    Link, H
    Arseniev, L
    Ganser, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S93 - S93
  • [39] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O.
    Gutierrez, H.
    Ruiz, G.
    Lopez, A.
    Mancias, C.
    Martinez, S.
    Gonzalez, O.
    Jaime, J.
    Gomez, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 653 - 653
  • [40] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O. G.
    Gutierrez, H.
    Ruiz, G.
    Mancias, C.
    Martinez, S. A.
    Gonzalez, O.
    Jaime, J. C.
    Gomez, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S314 - S314